Representing over 60% of our recent experience, Oncology studies are one of the areas in which Ergomed excels with our strong operational team and a unique specialised site support model.
As a full-service, global CRO specializing in oncology clinical research we have participated in a broad range of clinical research studies. Focused solely on biopharmaceutical clients, we strive to form lasting partnerships with our clients to deliver novel oncology treatments to patients.
Our experience is therapeutically diverse and broad covering all phases of clinical trials and study designs.
Our oncology experience encompasses over 335 oncology studies in all phases reaching over 35,000 patients and 1,300 investigative sites globally.
This therapeutic experience includes but is not limited to:
• Metastatic Breast Cancer
• Endometrial Cancer
• Head & Neck Carcinoma
• Metastatic Colon Carcinoma
• Ovarian Cancer
• Renal Cell Carcinoma
We also have experience with complex programs such as:
• Oncolytic virus
• Stem cell therapy
• Cellular therapy
• Gene therapy
Over 50% of our current oncology experience is in early phase oncology. These studies drive a higher level of oversight, monitoring and support.
Our clinical teams are seasoned, strong leaders who have proven records of delivery. Pairing this with our unique site management and study physician models, we are better able to support sites, resulting in quicker enrolment, and higher quality of samples and patients able to identify and enrol patients across the globe, while ensuring compliance to local regulatory requirements. Furthermore, our full-service offering allows us to provide a complete solution for your program’s unique requirements.
From our founding as an oncology focused CRO with a proven record of delivery, to holding one of the industry’s seasoned oncology clinical teams today, customers trust Ergomed to run their most challenging oncology trials.
Ergomed “White-Glove” Complete Solutions for Oncology Trials
Oncology trials are becoming increasingly complex, with a focus on specific patient subpopulations, immune-oncology, personalised treatments and oncoviruses. These studies require a “white glove” approach to site management and monitoring to better support the study coordinator and the site in delivering high quality data and results. Ergomed’s Site Management Services is designed with the Study Coordinator and the Site Investigator at the center of our support model.
Ergomed’s Site Management Service provides the leading edge in site support and dealing with these complexities and logistical hurdles in today’s complex studies:
• Protocol specific training of key study staff and pharmacy teams
• Support in pharmacy and IP management
• Coordination of collection, processing and shipment of timely lab samples (i.e. PK and PD samples)
• Logistics coordination for cellular therapy
• Oversight and management of logistical couriers
• Patient and caregiver concierge services